GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the ALK kinase domain in complex with entrectinib

Analyse Crystal structure of the ALK kinase domain in complex with entrectinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5FTO
Type
protein
Length
298 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
ALK tyrosine kinase receptor
EC
2.7.10.1
UniProt
Q9UM73
Ligands
YMX
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AALK tyrosine kinase receptor (EC 2.7.10.1)protein29840% helix, 17% strandQ9UM73

Ligands and binding sites

  • YMX · Entrectinib · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12300.600.8031YMX
2750.340.7614empty

Compared structures

  • 5FTO · Crystal structure of the ALK kinase domain in complex with Entrectinib · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9UM73 · AlphaFold monomer V2.0 prediction for ALK tyrosine kinase receptor (Q9UM73) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.